Effect of Modified ERAS Protocol on Clinical Outcomes in Pediatric Patients With Appendectomy
Launched by KARADENIZ TECHNICAL UNIVERSITY · Jul 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special care plan called the Enhanced Recovery After Surgery (ERAS) protocol on children who undergo appendectomy, which is surgery to remove the appendix due to appendicitis. The goal of the trial is to see if this ERAS protocol, which includes over 20 different steps to help patients recover better before, during, and after surgery, can lead to quicker recovery times and fewer complications.
To participate in the trial, children aged 6 to 18 who are having an appendectomy may be eligible, provided they are generally healthy and do not have serious medical conditions that could complicate their recovery. Participants can expect a supportive care environment aimed at helping them recover quickly and safely after surgery. The trial is currently looking for volunteers, and parental consent will be required for those who are under 18.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥6 years and ≤18 years, girls or boys
- • Underwent appendectomy
- • Written informed consent or requirements of local/national ethical committee
- Exclusion Criteria:
- • ASA (American Society of Anesthesiologists, ASA) score of ≥ 3
- • Any comorbidity/contraindication that may prevent mobilization and oral feeding
About Karadeniz Technical University
Karadeniz Technical University is a prestigious academic institution located in Trabzon, Turkey, renowned for its commitment to advancing research and education in the fields of science and technology. As a clinical trial sponsor, the university leverages its extensive resources, expertise, and collaborative networks to conduct innovative research that enhances healthcare outcomes. With a focus on ethical standards and rigorous methodologies, Karadeniz Technical University aims to contribute valuable insights to medical science and improve patient care through well-designed clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trabzon, , Turkey
Patients applied
Trial Officials
Buket MERAL, Msc
Principal Investigator
Karadeniz Technical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported